BESSI, VALENTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.453
AS - Asia 8.729
EU - Europa 5.720
SA - Sud America 630
AF - Africa 144
OC - Oceania 85
Continente sconosciuto - Info sul continente non disponibili 2
Totale 24.763
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.272
HK - Hong Kong 2.876
RU - Federazione Russa 2.392
SG - Singapore 1.962
CN - Cina 1.931
IT - Italia 1.335
KR - Corea 605
BR - Brasile 481
VN - Vietnam 443
IE - Irlanda 366
DE - Germania 311
SE - Svezia 292
BD - Bangladesh 250
FI - Finlandia 218
IN - India 195
FR - Francia 192
PL - Polonia 166
GB - Regno Unito 156
ID - Indonesia 105
CA - Canada 104
AU - Australia 84
NL - Olanda 82
JO - Giordania 80
JP - Giappone 65
AR - Argentina 51
ES - Italia 48
MX - Messico 48
TR - Turchia 37
UA - Ucraina 35
AT - Austria 34
ZA - Sudafrica 33
IQ - Iraq 31
CO - Colombia 29
NG - Nigeria 28
BJ - Benin 18
EC - Ecuador 18
MA - Marocco 17
PH - Filippine 17
PK - Pakistan 17
SA - Arabia Saudita 16
AE - Emirati Arabi Uniti 14
CI - Costa d'Avorio 14
CZ - Repubblica Ceca 13
CH - Svizzera 11
PY - Paraguay 11
AZ - Azerbaigian 10
KE - Kenya 10
KZ - Kazakistan 10
UZ - Uzbekistan 10
VE - Venezuela 10
CL - Cile 9
BE - Belgio 8
TW - Taiwan 8
UY - Uruguay 8
BG - Bulgaria 7
DZ - Algeria 7
EG - Egitto 7
PE - Perù 7
GR - Grecia 6
NP - Nepal 6
PA - Panama 6
IL - Israele 5
OM - Oman 5
BO - Bolivia 4
CR - Costa Rica 4
DK - Danimarca 4
HN - Honduras 4
JM - Giamaica 4
KG - Kirghizistan 4
LB - Libano 4
LT - Lituania 4
LV - Lettonia 4
PT - Portogallo 4
QA - Qatar 4
RS - Serbia 4
TN - Tunisia 4
AL - Albania 3
BA - Bosnia-Erzegovina 3
DO - Repubblica Dominicana 3
EE - Estonia 3
GE - Georgia 3
HU - Ungheria 3
LU - Lussemburgo 3
MY - Malesia 3
NI - Nicaragua 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
GY - Guiana 2
IR - Iran 2
LI - Liechtenstein 2
NO - Norvegia 2
SI - Slovenia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TG - Togo 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
ET - Etiopia 1
GD - Grenada 1
Totale 24.750
Salva come PNG Salva come JPEG
Città #
Hong Kong 2.794
Santa Clara 2.190
Singapore 1.505
Ashburn 1.488
Hefei 669
Seoul 599
San Jose 486
Dallas 478
Fairfield 395
Dublin 365
Chandler 345
Beijing 236
Milan 220
Seattle 198
Council Bluffs 197
Houston 191
Woodbridge 178
Los Angeles 176
Warsaw 162
Munich 151
Ho Chi Minh City 144
Buffalo 143
New York 142
Wilmington 132
Cambridge 129
Moscow 125
Altamura 122
Florence 118
The Dalles 114
Lauterbourg 113
Lawrence 113
Hanoi 111
Rome 105
Helsinki 97
Kent 97
Jakarta 87
Melbourne 80
Mumbai 75
Princeton 66
Shanghai 65
Ann Arbor 58
Tokyo 58
Boardman 53
Lappeenranta 53
São Paulo 53
Bremen 52
Boston 48
Dearborn 47
Turku 47
San Diego 41
Frankfurt am Main 40
Bengaluru 39
Orem 39
Medford 37
Naples 37
Jacksonville 36
Chicago 34
Paris 34
Montreal 33
Toronto 31
Abuja 27
London 27
Palermo 27
Denver 26
San Francisco 26
Atlanta 23
Brooklyn 23
Bologna 22
Chennai 22
Figino 22
Haiphong 22
Pune 22
Guangzhou 21
Stockholm 20
West Jordan 20
Cotonou 18
Da Nang 18
Johannesburg 18
Manchester 18
Nuremberg 18
Poplar 18
Turin 18
Vienna 18
Phoenix 15
Yubileyny 15
Abidjan 14
Baghdad 13
Mexico City 13
Prato 13
Rio de Janeiro 13
Salt Lake City 13
Tianjin 13
Amsterdam 12
Bari 12
Clifton 12
Falls Church 12
Izmir 12
Charlotte 11
City of London 11
Genoa 10
Totale 16.779
Salva come PNG Salva come JPEG
Nome #
Behavioural disorders in Alzheimer's disease: the descriptive and predictive role of brain 18F-fluorodesoxyglucose-positron emission tomography 2.299
Clinical and neuroimaging profiles to identify C9orf72-FTD patients and serum Neurofilament to monitor the progression and the severity of the disease 400
A new national survey of centers for cognitive disorders and dementias in Italy 253
Correlati Neurali del Deficit Mnesico: Studio VBM e DTI in soggetti affetti da Disturbo Soggettivo di Memoria, Mild Cognitive Impairment e Malattia di Alzheimer 233
Alzheimer's Disease CSF Biomarker Profiles in Idiopathic Normal Pressure Hydrocephalus 229
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study 229
Acute Symptomatic Sinus Bradycardia in High-Dose Methylprednisolone Therapy in a Woman With Inflammatory Myelitis: A Case Report and Review of the Literature 224
Association of the New Variant Tyr424Asp at TBK1 Gene with Amyotrophic Lateral Sclerosis and Cognitive Decline 220
Association analysis of the paraoxonase-1 gene with Alzheimer's disease 215
Challenges in Alzheimer's Disease Diagnostic Work-Up: Amyloid Biomarker Incongruences 214
Apathy in presymptomatic genetic frontotemporal dementia predicts cognitive decline and is driven by structural brain changes 212
Assessing the effectiveness of subjective cognitive decline plus criteria in predicting the progression to Alzheimer’s disease: an 11-year follow-up study 209
A case of atypical early-onset Alzheimer’s disease carrying the missense mutation Thr354Ile in exon 10 of the PSEN1 gene 203
Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations 200
Association of IL10 promoter polymorphism in Italian Alzheimer's disease. 200
The implication of BDNF Val66Met polymorphism in progression from subjective cognitive decline to mild cognitive impairment and Alzheimer's disease: a 9-year follow-up study 197
From Subjective Cognitive Decline to Alzheimer's Disease: The Predictive Role of Neuropsychological Assessment, Personality Traits, and Cognitive Reserve. A 7-Year Follow-Up Study 197
Dual Effect of PER2 C111G Polymorphism on Cognitive Functions across Progression from Subjective Cognitive Decline to Mild Cognitive Impairment 194
Cognitive composites for genetic frontotemporal dementia: GENFI-Cog 193
Brain functional network integrity sustains cognitive function despite atrophy in presymptomatic genetic frontotemporal dementia 191
CAG Repeats Within the Non-pathological Range in the HTT Gene Influence Personality Traits in Patients With Subjective Cognitive Decline: A 13-Year Follow-Up Study 191
A Pan-European study of theC9orf72Repeat Associated with FTLD: Geographic Prevalence, Genomic Instability and Intermediate Repeats 189
Autosomal Dominant Frontotemporal Lobar Degeneration Due to the C9ORF72 Hexanucleotide Repeat Expansion: Late-Onset Psychotic Clinical Presentation 188
Long-term use of pharmacological treatment in Alzheimer's disease: a retrospective cohort study in real-world clinical practice 188
Deleterious ABCA7 mutations and transcript rescue mechanisms in early onset Alzheimer’s disease 187
KIBRA T allele influences memory performance and progression of cognitive decline: a 7-year follow-up study in subjective cognitive decline and mild cognitive impairment 187
Implication of serotonin-transporter (5-HTT) gene polymorphism in subjective memory complaints and mild cognitive impairment (MCI). 185
Analysis of brain atrophy and local gene expression in genetic frontotemporal dementia 185
Differences and Similarities in Empathy Deficit and Its Neural Basis between Logopenic and Amnesic Alzheimer's Disease 184
Unravelling neural correlates of empathy deficits in Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer's Disease 184
High Frequency of Crossed Aphasia in Dextral in an Italian Cohort of Patients with Logopenic Primary Progressive Aphasia 183
Influence of apoe genotype and clock t3111c interaction with cardiovascular risk factors on the progression to alzheimer’s disease in subjective cognitive decline and mild cognitive impairment patients 182
Per2 C111G polymorphism influences cognition in Subjective Cognitive Decline and Mild Cognitive Impairment. A 10-year follow-up study 182
Linguistic profiles, brain metabolic patterns and rates of amyloid-β biomarker positivity in patients with mixed primary progressive aphasia 182
Loss of speech and functional impairment in Alzheimer's disease-related primary progressive aphasia: predictive factors of decline 181
Early structural changes in individuals at risk of familial Alzheimer's disease: a volumetry and magnetization transfer MR imaging study. 181
The role of plasma neurofilament light chain and glial fibrillary acidic protein in subjective cognitive decline and mild cognitive impairment 180
BPSDiary study protocol: a multi-center randomized controlled trial to compare the efficacy of a BPSD diary vs. standard care in reducing caregiver's burden 180
Temporal order of clinical and biomarker changes in familial frontotemporal dementia 179
Intermediate alleles of HTT: A new pathway in longevity 178
Plasma neurofilament light chain predicts Alzheimer's disease in patients with subjective cognitive decline and mild cognitive impairment: A cross-sectional and longitudinal study 177
FDG PET in the differential diagnosis of degenerative parkinsonian disorders: usefulness of voxel-based analysis in clinical practice 176
Cerebrospinal fluid biomarkers for dementia: A case of post-lumbar puncture epidural hematoma 176
Pattern and progression of cognitive decline in Alzheimer's disease:role of premorbid intelligence and ApoE genotype 176
Behavioral and psychological effects of coronavirus disease-19 quarantine in patients with dementia 176
Data-driven staging of genetic frontotemporal dementia using multi-modal MRI 175
Angiotensin converting enzyme insertion/deletion polymorphism in sporadic and familial Alzheimer's disease and longevity 175
Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia 175
Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease 174
Cerebral amyloid load determination in a clinical setting: interpretation of amyloid biomarker discordances aided by tau and neurodegeneration measurements 173
Neurofilament Light Chain and Intermediate HTT Alleles as Combined Biomarkers in Italian ALS Patients 173
Degradation of EEG microstates patterns in subjective cognitive decline and mild cognitive impairment: Early biomarkers along the Alzheimer’s Disease continuum? 172
The dual role of cognitive reserve in subjective cognitive decline and mild cognitive impairment: a 7-year follow-up study 172
Creutzfeldt-Jakob Disease in a Patient with Previous COVID-19 Infection: "The Virus Caused the Derangement in My Brain" 166
The Frequency of Intermediate Alleles in Patients with Cerebellar Phenotypes 165
Education modulates brain maintenance in presymptomatic frontotemporal dementia 165
Emotional dysregulation, alexithymia and neuroticism: a systematic review on the genetic basis of a subset of psychological traits 164
Citrate-capped gold nanoparticles as colorimetric sensors for amyloid ßpeptide (1-42) targeting in liquid samples 163
Alice in wonderland syndrome “through the looking-glass” in a rare presentation of non-convulsive status epilepticus in cerebral venous sinus thrombosis and COVID-19 163
Huntingtin gene intermediate alleles influence the progression from subjective cognitive decline to mild cognitive impairment: A 14-year follow-up study 163
Disentangling empathy impairment along Alzheimer's disease continuum: From subjective cognitive decline to Alzheimer's dementia 163
Heterogeneity and overlap in the continuum of linguistic profile of logopenic and semantic variants of primary progressive aphasia: a Profile Analysis based on Multidimensional Scaling study 162
PRedicting the EVolution of SubjectIvE Cognitive Decline to Alzheimer’s Disease With machine learning: the PREVIEW study protocol 161
Lack of implication for CALHM1 P86L common variation in Italian patients with early and late onset Alzheimer's disease. 161
Early functional MRI changes in a prodromal semantic variant of primary progressive aphasia: a longitudinal case report 161
Comparing two picture naming tasks in primary progressive aphasia: Insights from behavioural and neural results 158
Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia 157
Regional analysis of the magnetization transfer ratio of the brain in mild Alzheimer disease and amnestic mild cognitive impairment 156
A case of hemichorea/hemiballismus in a patient with Alzheimer’s disease and history of Sydenham’s chorea: the return of an old acquaintance? 155
Future perspective and clinical applicability of the combined use of plasma phosphorylated tau 181 and neurofilament light chain in Subjective Cognitive Decline and Mild Cognitive Impairment 155
Alzheimer Disease detection from Raman spectroscopy of the cerebrospinal fluid via topological machine learning 155
Impairment of episodic memory in genetic frontotemporal dementia: A genfi study 155
Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study 154
Brain metabolic connectivity reconfiguration in the semantic variant of primary progressive aphasia 154
Development of a sensitive trial-ready poly(GP) CSF biomarker assay for C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis 153
Crossed aphasia confirmed by fMRI in a case with nonfluent variant of primary progressive aphasia carrying a GRN mutation 153
Semantic dementia associated with mutation V363I in the tau gene. 152
Gender differences in cognitive reserve: implication for subjective cognitive decline in women 152
Plasma neurofilament light chain as a biomarker of Alzheimer's disease in Subjective Cognitive Decline and Mild Cognitive Impairment 151
Common and rare TBK1 variants in early-onset Alzheimer disease in a European cohort 151
Parkinson-ALS with a novel MAPT variant 150
Crossed aphasia in nonfluent variant of primary progressive aphasia carrying a GRN mutation 150
Putative novel CSF biomarkers of Alzheimer’s disease based on the novel concept of generic protein misfolding and proteotoxicity: the PRAMA cohort 148
A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia 146
GRN Missense Variants and Familial Alzheimer’s Disease: Two Case Reports 145
KIBRA gene variants are associated with episodic memory performance in subjective memory complaints. 145
Comprehensive qualitative characterization of linguistic performance profiles in primary progressive aphasia: a multivariate study with FDG-PET 144
Being the Family Caregiver of a Patient With Dementia During the Coronavirus Disease 2019 Lockdown 144
The effect of cag repeats within the non-pathological range in the htt gene on cognitive functions in patients with subjective cognitive decline and mild cognitive impairment 144
Differential early subcortical involvement in genetic FTD within the GENFI cohort 144
Cerebellar and subcortical atrophy contribute to psychiatric symptoms in frontotemporal dementia 143
A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study 142
Loss of brainstem white matter predicts onset and motor neuron symptoms in C9orf72 expansion carriers: a GENFI study 141
Suitability of neuropsychological tests in patients with vascular dementia (VaD). 140
Examining empathy deficits across familial forms of frontotemporal dementia within the GENFI cohort 139
Motor symptoms in genetic frontotemporal dementia: developing a new module for clinical rating scales 139
New insights into the genetic etiology of Alzheimer's disease and related dementias 139
Plasma p-tau181 as a promising non-invasive biomarker of Alzheimer's Disease pathology in Subjective Cognitive Decline and Mild Cognitive Impairment 137
Mutation analysis of patients with neurodegenerative disorders using NeuroX array 136
Different implication of NEDD9 genetic variant in early and late-onset Alzheimer's disease 136
Totale 19.578
Salva come PNG Salva come JPEG
Categoria #
all - tutte 70.777
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.777
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022495 11 17 36 16 10 26 9 60 31 20 102 157
2022/20231.648 152 357 82 162 94 273 217 74 179 11 34 13
2023/20241.208 31 66 99 48 70 114 70 438 31 120 84 37
2024/20257.168 215 690 406 1.014 1.823 1.037 141 423 277 262 370 510
2025/202612.691 1.075 3.478 1.512 901 1.206 332 1.108 457 558 661 468 935
2026/202725 25 0 0 0 0 0 0 0 0 0 0 0
Totale 24.961